Dale L Boger

La Jolla, CA, United States of America

Dale L Boger

USPTO Granted Patents = 48 

 

 

Average Co-Inventor Count = 1.2

ph-index = 14

Forward Citations = 467(Granted Patents)


Company Filing History:


Years Active: 1995-2021

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
TLR Agonists
Vinca Alkaloids
Antimicrobial Potency
Vancomycin Analogs
Antibody-Drug Conjugates
Fatty Acid Amide Hydrolase
Angiogenesis Inhibition
Serotonin Receptor Potentiation
Combinatorial Libraries
Duocarmycin Analogs
Multidrug Resistance
Cyclic Prodrugs
48 patents (USPTO):Explore Patents

Title: Dale L. Boger: A Pioneer in Pharmaceutical Innovations

Introduction

Dale L. Boger is a distinguished inventor based in La Jolla, California, known for his groundbreaking contributions to the field of pharmaceuticals. With an impressive portfolio of 48 patents, his work primarily focuses on the development of innovative drug compounds and therapeutics.

Latest Patents

Among Boger's latest noteworthy patents is his work on Diprovocims, which represents a new and potent class of Toll-like receptor (TLR) agonists. This class of compounds displays immune-adjuvant properties, demonstrating remarkable efficacy on both human and mouse cells in culture, as well as in vivo immunization of mice. The diprovocim compounds are characterized by unique structural properties that facilitate their use in immunostimulatory applications, rivaling the activity of Lipopolysaccharides (LPS) despite no apparent structural similarity.

Additionally, Boger has developed ultra-potent vinca alkaloids, which exhibit significant enhancements in binding affinity and biological activity compared to natural products. His synthetically-derived modifications of 20'-hydroxy-vinca derivatives such as vinblastine and vincristine show a staggering 100-fold increase in activity. These advancements in total synthesis strategies pave the way for better-targeted therapies against cancer cells, highlighting the potential for improved pharmaceutical compositions derived from natural products.

Career Highlights

Dale L. Boger has made significant strides in his career, conducting research and development at prominent institutions. He has been associated with The Scripps Research Institute and the University of Texas System, where he has leveraged his innovative approach to push the boundaries of pharmaceutical sciences.

Collaborations

Throughout his career, Boger has collaborated with noted scientists and researchers, including Richard A. Lerner and Steven J. Henriksen. These collaborations have facilitated the exchange of knowledge and expertise, contributing to the success of many of his inventions.

Conclusion

Dale L. Boger exemplifies the spirit of innovation in the field of pharmaceuticals. His latest patents showcase his commitment to advancing medical science through novel compounds that hold the promise of significant therapeutic benefits. With a robust background in research and numerous collaborations, he continues to influence the landscape of pharmaceutical development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…